ASCENT-IBO supports multidisciplinary teams conducting Phase 1 and 2 ibogaine trials to establish safety and effectiveness for high-risk opioid use disorder and prepare for Phase 3 testing.
This grant supports clinical trials and research to improve pain management, addiction treatment, anesthesia safety, and drug prescribing practices.
Use existing data to analyze drug use behaviors, prevention strategies, and service utilization, aiming to advance substance use research.
This grant supports research using advanced single cell techniques to study how substance use disorders and HIV interact in the brain, aiming to uncover mechanisms and identify new therapy targets.
Supports high-risk, high-impact research on HIV and substance use to advance HIV prevention, diagnosis, treatment, and virus suppression among people who use substances or have substance use disorders.
NIH seeks a single center to coordinate research, build capacity, assess barriers, and develop resources supporting integrated care for chronic pain and opioid use disorder; clinical trials are not allowed.